TY  - JOUR
T1  - REstoring confidence in the pharmaceutical industry
AU  - Bauchner H, Fontanarosa PB
Y1  - 2013/02/13
N1  - 10.1001/jama.2013.58
JO  - JAMA
SP  - 607
EP  - 609
VL  - 309
IS  - 6
N2  - 
Lack of trust in the pharmaceutical industry threatens the future of biomedical research. Although more than half of funded clinical trials in the United States are supported by industry1 and many scientists, clinicians, and others in industry are committed to advancing biomedical science and improving the health of patients, there is a need to restore confidence in pharmaceutical companies and the research they sponsor. As editors of a journal that publishes articles supported by industry, we are familiar with many of the complicated issues related to industry-supported and industry-analyzed studies. We have had discussions with leaders of the pharmaceutical industry about concerns they have regarding the erosion of trust in their companies. We also have had discussions with academic leaders and leading scientists about ways to improve the reputation of pharmaceutical industry research and have participated in initiatives to harmonize reporting by physicians, investigators, and others who have financial relationships with industry and other conflicts of interest.2

SN  - 0098-7484
M3  - doi: 10.1001/jama.2013.58
UR  - http://dx.doi.org/10.1001/jama.2013.58
ER  -